Our previous study revealed that large‐sized tumour cells expressed ten‐fold more NPM‐ALK mRNA transcripts than small‐sized tumour cells, indicating that large‐sized tumour cells acquiring L1196M ALK mutation can survive alectinib administration[7]. Here, ALK is linked to neoplasm.